Interferon-Alpha 2a Treatment of Neuro-Behcet Disease
- 1 June 2001
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
- Vol. 21 (2) , 109-111
- https://doi.org/10.1097/00041327-200106000-00011
Abstract
Behcet disease is a multisystemic, chronic, recurrent inflammatory disorder characterized as a triad of hypopyon uveitis, oral aphthae, and genital ulcers. Neurologic involvement in Behcet disease (neuro-Behcet) is common. Neuro-Behcet disease typically manifests late after disease onset, rarely coincides with ocular involvement, and often heralds a poor prognosis for final vision and survival. We present a case of neuro-Behcet disease with neurologic onset concomitant with systemic and ocular involvement that was responsive to treatment with interferon-alpha 2a.Keywords
This publication has 6 references indexed in Scilit:
- RETRACTED: Interferon alfa-2b, colchicine, and benzathine penicillin versus colchicine and benzathine penicillin in Behçet's disease: a randomised trialThe Lancet, 2000
- Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patientsBrain, 1999
- Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapyOphthalmology, 1999
- Treatment of ocular symptoms of Behcet's disease with interferon alpha 2a: a pilot studyBritish Journal of Ophthalmology, 1998
- Behçet's disease and the nervous systemZeitschrift für Neurologie, 1998
- Central nervous system toxicity related to FK506 in patients with Behçet's disease.Annals of the Rheumatic Diseases, 1994